Q-omics provides the consensus-scored SNORD65B profile across patient tissues and cancer cell-line models. SNORD65B expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, SNORD65B RNA expression shows 5,828 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where SNORD65B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.